Biotechnology
News Category
VERAXA Biotech Gains Regulatory Support from Germany’s PEI for BiTAC®-TCE Development
VERAXA Biotech received Scientific Advice from Germany’s Paul-Ehrlich-Institute, providing positive regulatory feedback on its BiTAC®-TCE platform, wh...
Onco-Innovations Advances Precision Oncology with ONC010 for Biomarker-Selected Cancers
Onco-Innovations is developing ONC010, a nanoparticle-encapsulated PNKP inhibitor for biomarker-selected cancers, aligning with the growing shift towa...
Lantern Pharma Receives U.S. Patent Allowance for LP-184 Biomarker-Based Cancer Treatment Methods
Lantern Pharma announced a U.S. patent allowance for methods to select and treat patients with certain cancers using its investigational therapy LP-18...
VERAXA Biotech Appoints Christoph Erkel as Chief Scientific Officer to Advance BiTAC Platform
VERAXA Biotech AG announced the appointment of Christoph Erkel as chief scientific officer, bringing two decades of antibody engineering experience to...
BioAdaptives Completes Manufacturing and Logistics for Wellness Product Launch, Targeting Cognitive and Cellular Health Markets
BioAdaptives Inc. has finished commercial manufacturing and supply chain preparations, positioning the company to launch its MyndSystem cognitive perf...
iOrganBio Appoints Lee L. Rubin, Ph.D. to Scientific Advisory Board
iOrganBio adds stem cell biology expert Lee L. Rubin, Ph.D. to its Scientific Advisory Board to advance its AI-driven cell manufacturing platform for ...
Creative Biolabs Expands Microfluidics Portfolio to Accelerate High-Throughput Antibody Discovery
Creative Biolabs launches an integrated microfluidics platform combining droplet generation systems, customizable chips, and immune checkpoint service...
Quantum BioPharma Targets Brain Disorders with Dual Pipeline Approach
Quantum BioPharma is developing Lucid-MS for multiple sclerosis and unbuzzd for alcohol intoxication, addressing significant unmet needs in neurologic...
Oncotelic Therapeutics Publishes Preclinical Data Supporting Intravenous Cancer Therapy Sapu003
Oncotelic Therapeutics published a peer-reviewed study in Biomedicines detailing preclinical data for Sapu003, its intravenous everolimus formulation,...
Kairos Pharma Collaborates With Bayer to Evaluate Combination Therapy for Advanced Prostate Cancer
Kairos Pharma has partnered with Bayer to study its lead antibody ENV-105 in combination with XOFIGO for metastatic castration-resistant prostate canc...
VERAXA Biotech Advances BiTAC(R)-TCE Development with Positive Regulatory Feedback from Germany
VERAXA Biotech AG received Scientific Advice from Germany's Paul-Ehrlich-Institute, supporting its lead BiTAC(R)-TCE program's development strategy an...
VivoSim Labs Raises $4 Million in Private Placement to Advance Drug Testing Technology
VivoSim Labs announced a $4 million private placement with a healthcare-focused institutional investor to fund working capital and general corporate p...
Greenwich LifeSciences Provides Update on Phase 3 FLAMINGO-01 Trial for Breast Cancer Immunotherapy GLSI-100
Greenwich LifeSciences announced that its Phase 3 FLAMINGO-01 trial for GLSI-100, an immunotherapy to prevent breast cancer recurrence, continues as r...
Quantum BioPharma Targets Unmet Needs in Neurological Disorders with Two Distinct Programs
Quantum BioPharma Ltd. is advancing a novel MS therapy and a hangover supplement to address significant gaps in neurological care, potentially impacti...
American Fusion Secures Texas Certificate of Registration for Texatron Fusion Engine Testing
American Fusion Inc. received a Texas DSHS Certificate of Registration for Industrial Radiation Machines, enabling testing of its Texatron Fusion Engi...
WHO-Commissioned Study Finds No Evidence Mobile Phones Cause Brain Cancer
A comprehensive review commissioned by the World Health Organization found no link between mobile phone use and brain cancer, addressing long-standing...
Quantum BioPharma Hits Key Study Milestone as Early MS Imaging Data Shows Promising Signal
Quantum BioPharma announces that its imaging study for multiple sclerosis has reached halfway in patient enrollment, with early data showing a promisi...
GeoVax's GEO-MVA Platform Aligns with HHS/ASPR Five-Year Medical Countermeasure Preparedness Strategy
GeoVax Labs highlights how its GEO-MVA vaccine platform aligns with the U.S. Department of Health and Human Services' ASPR five-year plan, which empha...
VERAXA Biotech Receives Regulatory Feedback for BiTAC-TCE Cancer Therapy Platform
VERAXA Biotech received Scientific Advice from Germany's Paul-Ehrlich-Institute, validating the biological rationale and development strategy for its ...
VERAXA Biotech Receives Regulatory Feedback for BiTAC-TCE Cancer Therapy Platform
VERAXA Biotech AG announced positive regulatory feedback from Germany's Paul-Ehrlich-Institute for its BiTAC-TCE platform, advancing the program towar...
Regentis Biomaterials Secures Japan Patent Allowance for GelrinC Manufacturing Technology
Regentis Biomaterials received a Japan patent allowance for its proprietary GelrinC manufacturing process, strengthening its IP portfolio and position...
MindBio Therapeutics Advances Voice-Based AI Tech for Real-Time Impairment Detection
MindBio Therapeutics is developing an AI-powered voice analysis platform to detect drug and alcohol impairment from short speech samples, offering a n...
Gut Microbial Metabolites Linked to Improved Cancer Immunotherapy Response
A recent study identifies gut microbial metabolites that enhance sensitivity to cancer immunotherapy, offering new avenues for treatment optimization.
SS Innovations Appoints Veteran Medtech CFO as Global Robotic Surgery Expansion Accelerates
SS Innovations International has appointed Sarah M. Romano as CFO, bringing over $100 million in capital markets experience as the company pursues FDA...
Creative Biolabs Integrates Microfluidics and Electrochemical Biosensors to Accelerate Next-Generation POCT Diagnostics
Creative Biolabs expands its platform by combining microfluidics and electrochemical biosensors to address the challenges of point-of-care testing, en...
BioAdaptives Details Scientific Strategy Behind Xcellara Platform Ahead of XcellaraHeart Launch
BioAdaptives outlined its Xcellara cellular wellness platform strategy, combining a stem cell mobilization base with tissue-specific ingredients, ahea...
NeuroOne Collaborates with Mayo Clinic on Pediatric Brain Cancer Trial Using Drug Delivery Platform
NeuroOne Medical Technologies announced a collaboration with Mayo Clinic to evaluate a novel treatment for pediatric diffuse midline glioma using its ...
Oncotelic Therapeutics Launches AI-Powered Manufacturing Platform to Bridge GMP Infrastructure Gap for Biotechs
Oncotelic Therapeutics introduces an AI-driven manufacturing services platform combining its PDAOAI architecture with robotics from TechForce Robotics...
Quantum BioPharma Advances Multiple Sclerosis Therapy LUCID-MS with FDA Submission and Planned Phase 2 Trial
Quantum BioPharma's LUCID-MS, a potential first-in-class neuroprotective therapy for multiple sclerosis, has progressed to a Phase 2 trial after showi...
VERAXA Biotech Leverages AI Collaboration to Advance Cancer Therapy Platform
VERAXA Biotech's partnership with AI firm Ardigen aims to enhance its BiTAC oncology platform through AI-enabled target discovery, positioning the com...
Tonix Pharmaceuticals Publishes Mpox Research Supporting TNX-801 Vaccine Development
New preclinical research published in the Journal of Virology shows that the mpox virus clade IIb circulating in the U.S. is up to 100,000 times less ...
Nuvectis Pharma Prices $100 Million Public Offering to Advance Pipeline
Nuvectis Pharma has priced a $100 million public offering to fund development of its NXP100, NXP200, and NXP900 programs, signaling strong investor co...
Kairos Pharma Reports Favorable Interim Phase 1 Safety Data for ENV-105 in EGFR-Mutated Lung Cancer
Kairos Pharma announced promising interim safety results from its Phase 1 trial of ENV-105 combined with osimertinib in advanced EGFR-mutated NSCLC, w...
NeuroThera Labs Initiates Phase IIb Clinical Trial for Tourette Syndrome Treatment at Hannover Medical School
NeuroThera Labs has started a Phase IIb trial for SCI-110, a cannabinoid-based treatment for Tourette Syndrome, at Hannover Medical School, aiming to ...
Earth Science Tech Leverages Telehealth and Peptide Therapy to Strengthen Market Position
Earth Science Tech Inc. is capitalizing on the booming telehealth and peptide therapy markets through its subsidiaries and proprietary technology, pos...
Formycon and OneSource Specialty Pharma Announce Strategic Manufacturing Partnership for Biosimilars
Formycon AG and OneSource Specialty Pharma have formed a strategic partnership to leverage OneSource's manufacturing capabilities for cost-efficient p...
Quantum BioPharma Advances LUCID-MS Therapy for Multiple Sclerosis into Phase 2 Trials
Quantum BioPharma's LUCID-MS, a potential first-in-class neuroprotective therapy for multiple sclerosis, has shown favorable safety in Phase 1 studies...
Quantum BioPharma Advances LUCID-MS Toward Phase 2 Trial for Multiple Sclerosis
Quantum BioPharma's LUCID-MS therapy shows promise in Phase 1 safety trials, moving to Phase 2 after FDA application, potentially offering a first-in-...
Silo Pharma Subsidiary QwikAgents Joins AMD AI Developer Program, Bolstering AI Agent Platform Development
Silo Pharma's subsidiary QwikAgents has been accepted into the AMD AI Developer Program, gaining access to cloud credits, tools, and a global communit...
VERAXA Biotech Leverages AI to Enhance Cancer Therapy Platform
VERAXA Biotech's collaboration with AI firm Ardigen aims to use machine learning for target discovery in its BiTAC cancer therapy platform, highlighti...
Algene Holding Achieves First Microalgae Harvest, Launching Series Production for Cosmetics and Food Industries
Algene Holding SE, a subsidiary of DN Group AG, has successfully harvested 4,500 litres of high-purity microalgae, marking the start of series product...
VERAXA Biotech Partners With Ardigen to Advance AI-Driven Cancer Drug Development
VERAXA Biotech has partnered with Ardigen to integrate AI into its BiTAC pipeline, aiming to improve target selection and reduce toxicity in cancer dr...
NanoViricides Receives Ethics Approval for Phase II Ebola Trial in DRC
NanoViricides has obtained National Ethics Committee approval in the Democratic Republic of the Congo for a Phase II clinical trial of its oral NV-387...
Tonix Pharmaceuticals Expands TONMYA Medicare Coverage to 145 Million Lives
Tonix Pharmaceuticals announces a managed Medicare agreement that expands TONMYA coverage to approximately 145 million covered lives, representing 46%...
VERAXA Biotech Partners With Ardigen to Apply AI in Advancing Cancer Drug Development
VERAXA Biotech AG (NASDAQ: VRXA) announced a collaboration with Ardigen S.A. to integrate artificial intelligence into its BiTAC pipeline, aiming to e...
Onco-Innovations Completes Analytical Reference Standard for Lead Oncology Candidate ONC010
Onco-Innovations announced the completion of its analytical reference standard program for the active pharmaceutical ingredient supporting ONC010, a k...
VERAXA Biotech Appoints Carl von Halem as Interim CFO Amid Leadership Transition
VERAXA Biotech has appointed Carl von Halem as interim CFO, leveraging his experience in corporate finance and life sciences to guide the finance func...
Feeder-free TIL expansion reduces IL-2 dependence, enhances safety in preclinical study
A novel feeder-free TIL expansion platform reduces high-dose IL-2 reliance while maintaining anti-tumor efficacy, and combining with low-dose PD-1 blo...